Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Supriya Lifescience tanks 12%; why pharma stock under pressure?
Supriya Lifescience said proceedings were initiated against the personnel of the company under the NDPS Act, 1985 for a procedural lapse for a single export transaction of an identified producer.
Supriya Lifescience tanks 12%; what's ailing this pharma stock?
Supriya Lifescience said proceedings were initiated against the personnel of the company under the NDPS Act, 1985 for a procedural lapse for a single export transaction of an identified producer.
Glenmark Pharmaceuticals Ltd stays supported
Glenmark Pharmaceuticals Ltd is quoting at Rs 2260.5, up 2.24% on the day as on 12:49 IST on the NSE. The stock is up 21.53% in last one year as compared to a 4.02% slide in NIFTY and a 15.14% slide in the Nifty Pharma index.
Abbott India Ltd gains for fifth session
Abbott India Ltd is quoting at Rs 26830, up 3.61% on the day as on 12:44 IST on the NSE. The stock is down 22.2% in last one year as compared to a 3.99% gain in NIFTY and a 15.09% gain in the Nifty Pharma.
Suzuki Motor arm Next Bharat Ventures launches ₹2,000 crore second impact fund to back rural entrepreneurs
Next Bharat Venture’s second fund will focus on agriculture, financial inclusion, healthcare, and AI for social good among others.
Nifty Q1 earnings to grow 10%, highest in 4 quarters, says Motilal Oswal. Which sectors will take charge this quarter?
The June-quarter earnings season begins with TCS reporting on Thursday, with Motilal Oswal forecasting a 3% year-on-year earnings decline for its coverage universe—the weakest since September 2020. While large- and mid-cap companies are expected to post profit declines, small caps are projected to deliver 20% PAT growth.
Granules India gains after securing sole first-to-file ANDA status for LUMRYZ generic
Granules India rose 2.14% to Rs 851 after the company said that it has secured sole first-to-file (FTF) status for its abbreviated new drug application (ANDA) for sodium oxybate extended-release for oral suspension.
Glenmark Pharma jumps over 2% on launch of Olanzapine single-dose vial
Glenmark Pharma stock advanced over 2% in Monday's intra-day trade, after the company's US arm announced the launch of Olanzapine single-dose vial.
Fermenta Biotech soars after FSSAI approves plant-based Vitamin D3 ingredient
Fermenta Biotech surged 13.08% to Rs 387.85 after the company announced that its plant-based Vitamin D3 (Cholecalciferol), marketed under the brand VITADEE Green, has received FSSAI approval.
Volumes soar at Glaxosmithkline Pharmaceuticals Ltd counter
Glaxosmithkline Pharmaceuticals Ltd recorded volume of 1.82 lakh shares by 10:46 IST on BSE, a 17.18 times surge over two-week average daily volume of 10602 shares
True North cashes out $2 billion for investors as PE firms step up exits
This comes on the back of exits for True North from portfolio firms like FedFina, Niva Bupa, Biocon Biologics, Infinity Fincorp Solutions, Zydus Wellness and Home First Finance.
Metropolis Healthcare climbs as Q1 revenue climbs 16% YoY
Metropolis Healthcare jumped 2.97% to Rs 568.40 after the company's revenue grew around 16% YoY in Q1 FY27, driven by patient volumes along with realization benefits due to product mix change.